As experts in weight management, our board-certified team provides a holistic, supervised approach you wont find with one-size-fits-all programs
Participants receiving semaglutide 2.4 mg weekly achieved mean weight loss of 35 pounds, while those on placebo lost 6 pounds
The Glucagon-Like Peptide-1 (GLP-1) receptor agonist semaglutide was initially used for the treatment of type 2 diabetes and obesity [3, 4]
Meaningful fat loss indicators include measurable changes in body composition, increased energy during fasted states, and visible changes in stubborn fat areas
The Journal of Clinical Investigation (en ingls) 79 (2): 616-619
GMP: This product was manufactured in a GMP facility under strict quality control to assure consistent high quality that meets the requirements of the marketing authorization (MA) or product specification.